Your role
- We are seeking an experienced leader for our Drug Metabolism and Pharmacokinetics (DMPK) strategy for our small molecule drug discovery and development pipeline. In this newly created role, you will oversee all aspects of DMPK, ensuring the seamless integration of pharmacokinetic (PK) data and modeling strategies to drive preclinical and clinical development.
- You will be responsible for advancing our understanding of drug behavior in the body, with a specific focus on the use of preclinical PK data to model and simulate human pharmacokinetic profiles. You will apply advanced pharmacokinetic modeling and simulation (PK/PD) to predict human drug exposure, optimize dosing regimens, and support decision-making in early drug development.
What you'll do
- You will set the DMPK strategy for our discovery programs
- We'll look to you for the establishment and oversight of activities at CROs, including in vitro ADME, PK, bioanalysis and PK/PD modeling
- Utilize preclinical pharmacokinetic (PK) and pharmacodynamic (PD) data to build and validate predictive models for human pharmacokinetics and drug behavior. Work closely with cross-functional teams to establish optimal dose projections for human clinical trials.
- Human Dose Prediction: Apply modeling and simulation techniques to determine the predicted human pharmacokinetic profile, including dose selection, bioavailability, half-life, and drug-drug interaction potential, based on animal and in vitro data.
- You will be the functional area representative for DMPK on multidisciplinary project teams
- You will design, analyze and interpret preclinical DMPK studies in support of program goals
- You will also use a broad array of DMPK data to enable integrated analyses of biopharmaceutics, drug metabolism, PK/PD, human PK/dose projections and DDI risk
- You will be responsible for an internal data repository
- You will work directly with our computational chemistry team to establish and refine available predictive DMPK-property tools.
Your background
- You earned your Ph.D. with a focus in pharmacokinetics, pharmacology or related discipline.
- You have at least 10 years of experience in pharma and or a biotech setting.
- You have small molecule DMPK experience - this is a must.
- Have you spent time working specifically across multiple therapeutic areas in drug discovery? This is highly preferred.
- You have extensive experience optimizing and characterizing the ADME properties of small molecule drug candidates, supported by a strong publication record in DMPK sciences. You also bring expertise in the interplay between DMPK parameters, physicochemical and molecular properties
- Expertise in PK/PD modeling from discovery through early development. Proficient with Phoenix WinNonlin or similar.
- Experience leading DMPK on projects particularly in discovery and early development
- Operational experience and familiarity with the drug discovery and development process, including external regulatory requirements
- You're comfortable navigating complexity and ambiguity in an environment that is constantly changing, and even thrive in this. You're poised interacting with consultants, external vendors and internal cross-functional project teams. You also have track record of achieving results in a virtual/outsourced model
- You're an articulate, open communicator with the ability to analyze, interpret and present data in a clear manner
- Not a stranger to authoring and reviewing documents, you especially have a familiarity authoring and reviewing PK sections of regulatory dossiers
- Your colleagues would describe you as an open and articulate communicator.
- You bring an openness to learn from diverse perspectives and collaborate on multidisciplinary teams.
- You have a track record of scientific vigor and creativity in carrying out research
Similar Jobs
What We Do
5AM was founded in 2002 and pursues investments in advanced life science innovations, and seeks to be diversified across the biopharmaceutical therapeutics, and platform technologies. Within each sector, 5AM invests across multiple therapeutic areas and modalities and evaluates opportunities based on innovative platform technologies, corporate spin-offs and products with shorter development cycles.
Content 5AM shares on this platform is not, and may not be relied on, in any manner, as legal, tax, investment, accounting or other advice or as an offer to sell or a solicitation of an offer to buy an interest in any private fund, special purpose or other investment vehicle sponsored by 5AM Ventures. Content 5AM shares on this platform is not an investment recommendation.
For a full list of all 5AM portfolio companies, please visit: https://5amventures.com/portfolio/







